By Gabriel Montoya
Last Thursday, it was revealed on BoxingScene.com that Andre Berto failed one of his random drug tests that were administered by VADA [Voluntary Anti Drug Association]. Berto's A and B samples were confirmed to have had traces of nandrolone.
Berto is preparing for a welterweight rematch with Victor Ortiz on June 23rd at Staples Center in Los Angeles California. Both fighters had agreed to take part in a random drug testing protocol.
Sources have informed me that analysis of Berto's positive tests results for nandrosterone (a metabolic byproduct of nandrolone) revealed "ultra-trace amounts of Nandrolone in the low parts per trillion range and consistent with contamination not intent."
In other words, the amount in his system is so minute [very little] that it is highly unlikely that he intentionally ingested nandrolone but was rather contaminated by food or a supplement.
This is excellent news for Team Berto, essentially backing up the theory explained in my article "Andre Berto Tests Positive for The Molecule of the Month: Nandrolone."
Does this mean Berto/Ortiz II could have been saved?
BoxingScene first reported on Sunday afternoon that Josesito Lopez had accepted the opportunity to face Ortiz.
More details to come as the story breaks. Tags: Andre Berto , Victor Ortiz , Berto vs Ortiz , Berto-Ortiz